This episode of A Dose of Optimism explores how technology and compassion are reshaping the autism journey, from early diagnosis to innovative therapy.

Host Omkar Kulkarni talks with Dr. Colleen Kraft, past president of the American Academy of Pediatrics, about how pediatricians are identifying developmental differences earlier than ever. She explains how AI tools like Canvas Dx, developed by Cognoa, are helping families get answers faster and start life-changing interventions while children’s brains are still rapidly developing. Dr. Sharief Taraman, a pediatric neurologist and CEO of Cognoa, shares how technology is expanding access to care by reducing wait times and empowering more clinicians to diagnose and support children with autism.

The conversation continues with Vijay Ravindran, founder and CEO of Floreo, who describes how virtual reality is being used to teach social and life skills in a safe, immersive environment. His platform is helping children practice everything from crossing the street to making friends, turning therapy into a truly interactive learning experience.

From AI to VR, these breakthroughs are giving families hope, access, and the support they need, proving that innovation in children’s health is both possible and powerful.

Connect with Colleen Kraft:

Colleen Kraft LinkedIn

Connect with Sharief Taraman:

Cognoa Website

Cognoa Instagram

Sharief Taraman LinkedIn

Sharief Taraman Instagram

Connect with Vijay Ravindran:

Floreo Website

Floreo Instagram

Vijay Ravindran LinkedIn

Read:

NYC autism school embraces VR to teach social skills and boost learning

Schools turn to VR to develop a ‘future-ready’ neurodivergent workforce

For people with disabilities, stressful situations may be traumatic. VR can help | Opinion

Connect with us:

KidsX Website

KidsX LinkedIn

Children's Hospital L.A. Website

Children's Hospital L.A. Instagram

Children's Hospital L.A. LinkedIn

Learn more about our sponsor:

Nabla Website

Nabla LinkedIn